RecruitingNCT06794970
Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
50 participants
Start Date
May 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Age ≥18 years
- Kidney transplant recipients
- eGFR>15 ml/min/1.73 sq m at the time of diagnosis of cAMR
- cAMR diagnosis defined on the basis of the 2018 Banff Classification (17), made after 1/1/2018.
- Obtaining Informed Consent to Participation.
Exclusion Criteria2
- Combined transplant patients (heart-kidney, liver-kidney or kidney-pancreas)
- Histological evidence of concomitant disease (e.g. recurrence of original nephropathy or diagnosis of 'de novo' nephropathy, acute cellular rejection, polyomavirus BK nephropathy, other)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06794970
Related Trials
Advancing Transplantation Outcomes in Children
NCT0605560820 locations
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
NCT060561023 locations
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
NCT068557581 location
Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine
NCT076005412 locations
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
NCT037072621 location